Global Yeast Beta-Glucan Market Size, Share, And Enhanced Productivity By Type (1,3-glucan, 1,6-glucan), By Form (Soluble, Insoluble), By End-use (Food and Beverage Industry, Cosmetics and Skincare Industry, Animal Feed Industry, Agriculture Industry, Pharmaceutical), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2026-2035

Report Overview

The Global Yeast Beta-Glucan Market is expected to be worth around USD 733.2 million by 2035, up from USD 374.8 million in 2025. It is projected to grow at a CAGR of 7.0% from 2026 to 2035. Asia Pacific accounted for 42.3%, totaling USD 158.5 Mn, amid strong demand growth.

Yeast beta-glucan is a natural polysaccharide extracted from the cell walls of yeast, widely valued for its functional and bioactive properties. The most commercially relevant forms include 1,3-glucan and 1,6-glucan, both known for their role in supporting immune health, digestive wellness, and formulation stability. Depending on application needs, it is available in soluble and insoluble forms, allowing use across food systems, skincare bases, feed premixes, crop formulations, and pharmaceutical preparations.

The Yeast Beta-Glucan Market refers to the global commercial ecosystem surrounding the production, processing, and use of yeast-derived beta-glucan across industries such as food and beverage, cosmetics and skincare, animal feed, agriculture, and pharmaceutical applications. Demand continues to expand as manufacturers increasingly prefer multifunctional ingredients that offer nutritional value, texture enhancement, and health-supporting benefits within a single formulation platform.

A major growth factor for the market is the rising demand for functional ingredients that align with preventive health, clean-label preferences, and performance-based product development. Its increasing use in immunity-supporting foods, skin barrier formulations, livestock gut health, and crop resilience solutions continues to strengthen long-term industry adoption across both consumer and industrial sectors.

The market is also seeing strong demand and opportunity from expanding investments in biotechnology, agriculture, and fermentation-linked infrastructure. Recent developments, such as Full Circle Biotechnology securing funding for a 7,000-ton facility, Aviwell raising EUR 11 million, the Ensus bioethanol plant reopening with a £100 million funding deal, and multiple MDARD grants exceeding $250 million, $300,000, and $1.8 million, are creating favorable conditions for ingredient innovation, sustainable production, and wider end-use commercialization.

• In June 2025, Lesaffre Human Care, known for yeast fermentation and human health ingredients, expanded its yeast-derived solutions through a joint venture with Zilor after acquiring a 70% stake in Biorigin. This development strengthened its natural yeast ingredient capabilities for human nutrition and wellness applications, including beta-glucan-related innovation.

Key Takeaways

• The Global Yeast Beta-Glucan Market is expected to be worth around USD 733.2 million by 2035, up from USD 374.8 million in 2025. It is projected to grow at a CAGR of 7.0% from 2026 to 2035.
• In the Yeast Beta-Glucan Market, 1,3-glucan dominates type segmentation, capturing 54.8% share through proven efficacy.
• Soluble forms lead the Yeast Beta-Glucan Market with 59.7% share, favored for versatile formulation applications.
• Food and beverage applications command 36.9% of the Yeast Beta-Glucan Market demand, driven by functional nutrition.
• In the Asia Pacific, valuation hit USD 158.5 Mn, capturing 42.3% regional market share.

By Type Analysis

In the Yeast Beta-Glucan Market, 1,3-glucan dominates the type share at 54.8% globally today.

In 2025, the Yeast Beta-Glucan Market saw 1,3-glucan emerge as the leading type segment, accounting for 54.8% of total demand, reflecting its strong commercial relevance across nutrition, immunity, and specialty functional ingredient applications. This dominance is largely supported by the molecule’s well-established immune-modulating properties, making it highly preferred in dietary supplements, fortified foods, and preventive wellness formulations. Manufacturers increasingly favored 1,3-glucan derived from yeast because of its consistency, scalable production, and compatibility with clean-label product development trends.

Rising consumer interest in scientifically supported bioactive ingredients further strengthened demand across global markets. In addition, expanding use in pharmaceutical adjuncts and personal care formulations contributed to broader segment penetration, helping 1,3-glucan maintain its leadership position within the evolving yeast beta-glucan industry landscape.

By Form Analysis

Soluble form leads the Yeast Beta-Glucan Market with 59.7% demand across applications worldwide.

In 2025, the soluble form segment held 59.7% of the Yeast Beta-Glucan Market, highlighting its superior adoption across industries requiring easy formulation, higher bioavailability, and smooth integration into liquid and semi-solid products. Soluble yeast beta-glucan remained especially attractive to manufacturers in beverages, dietary powders, syrups, and nutraceutical blends because it disperses efficiently without compromising texture or stability. The segment’s growth was further supported by increasing demand for functional ingredients that can be incorporated into ready-to-drink wellness products and fortified nutritional solutions.

Its ability to support digestive health, immune response, and cholesterol management also enhanced consumer acceptance. As product innovation accelerated in health-focused consumables, the soluble form continued gaining preference among formulators seeking versatile, science-backed ingredients with broad application flexibility and strong market acceptance.

By End-use Analysis

The food and beverage industry drives 36.9% of the Yeast Beta-Glucan Market consumption globally.

In 2025, the food and beverage industry represented 36.9% of the Yeast Beta-Glucan Market by end use, making it the largest application area as brands expanded their focus on functional nutrition and immunity-supporting products. Food manufacturers increasingly incorporate yeast beta-glucan into bakery products, dairy alternatives, soups, nutrition bars, and health beverages to enhance product value and align with rising wellness-driven consumer preferences. The ingredient’s natural origin, fiber enrichment benefits, and compatibility with clean-label trends made it particularly attractive in premium product development.

Beverage companies also leveraged it in fortified drinks and meal-replacement formulations aimed at digestive and immune health support. Strong consumer demand for preventive nutrition, combined with continuous innovation in fortified foods, positioned the food and beverage sector as the primary growth engine for the yeast beta-glucan market throughout 2025.

Key Market Segments

By Type

• 1,3-glucan
• 1,6-glucan

By Form

• Soluble
• Insoluble

By End-use

• Food and Beverage Industry
• Cosmetics and Skincare Industry
• Animal Feed Industry
• Agriculture Industry
• Pharmaceutical

Driving Factors

Rising functional food and nutrition demand

The Yeast Beta-Glucan Market is strongly supported by rising demand for functional food and nutrition products, as manufacturers continue integrating yeast beta-glucan into immunity-supporting, fiber-enriched, and wellness-oriented formulations. Growth in school nutrition and community food supply systems further strengthens this demand outlook.

A supportive example is the USDA issuing a $250k grant to a farm co-op scheme to supply vegetables to schools, which reflects broader momentum toward healthier food ecosystems and nutrient-focused ingredient adoption. Such funding-backed food distribution and nutrition improvement initiatives create favorable long-term opportunities for yeast beta-glucan use in fortified foods, daily dietary products, and preventive wellness solutions across mainstream consumer markets.

Expanding pharmaceutical and feed applications globally

The Yeast Beta-Glucan Market is also driven by expanding pharmaceutical and feed applications, where the ingredient is increasingly valued for immune support, gut balance, and performance-enhancing formulation roles. Its growing inclusion in animal nutrition and therapeutic support products continues to strengthen market demand worldwide.

Even with policy shifts such as the USDA cancelling a $300M grant program affecting projects for underserved Minnesota farmers, the broader need for efficient feed systems and health-supporting livestock nutrition remains strong. This sustained application demand across the pharmaceutical and feed industries continues to reinforce the commercial importance of yeast beta-glucan in advanced formulation systems globally.

Restraining Factors

High extraction and purification costs

A major restraint in the Yeast Beta-Glucan Market remains the high cost associated with extraction, purification, and quality standardization, especially for applications requiring higher purity grades. Processing complexity, specialized equipment, and consistency requirements often increase operational burdens for producers.

At the same time, large-scale sustainability investments such as the Green Climate Fund approving a US$50 million project promoting climate-resilient agriculture highlight growing pressure on manufacturers to align with environmentally efficient production systems. While such initiatives support sustainable agriculture, they also indirectly raise expectations for cleaner and more resource-efficient ingredient processing, adding to cost-related challenges in yeast beta-glucan manufacturing.

Limited awareness in developing regions

Limited awareness regarding the functional and commercial benefits of yeast beta-glucan continues to restrain wider adoption in several developing regions. In many emerging markets, knowledge gaps across food, feed, agriculture, and health applications slow product acceptance and formulation uptake.

However, public support measures such as the government backing farmers with £345 million productivity and innovation funding indicate a stronger push toward education, modernization, and advanced agricultural inputs. Despite this positive environment, broader market penetration for yeast beta-glucan still depends on improving awareness, technical outreach, and localized product positioning among end users in developing economies.

Growth Opportunity

Expansion in regenerative agriculture solutions

The Yeast Beta-Glucan Market holds strong growth potential in regenerative agriculture solutions, where the ingredient is increasingly explored for soil vitality, plant resilience, and microbial balance applications. As agriculture systems move toward sustainability and export competitiveness, yeast-derived functional inputs are gaining strategic relevance.

A strong supporting development is the USDA announcing US$212mn agriculture export development funding, which creates a favorable environment for advanced biological and value-added agricultural solutions. This broader investment direction enhances the opportunity for yeast beta-glucan to expand into crop-support and regenerative farming applications over the coming years.

Increased soluble beta-glucan beverage innovations

Increasing innovation in soluble yeast beta-glucan beverages presents a major commercial opportunity, particularly as consumers prefer convenient immunity and digestive wellness drinks. Soluble formats support easy dispersion, better texture control, and clean-label beverage positioning, making them highly attractive in ready-to-drink applications.

Despite risks in funding ecosystems, such as Italy’s EPPO dismantling a criminal group behind €1.4 million agricultural funding fraud, the broader innovation momentum in food and beverage science remains strong. This keeps soluble yeast beta-glucan well-positioned for expansion in functional beverages, nutritional shots, and fortified drink mixes.

Latest Trends

Clean-label yeast ingredient product development

A leading trend in the Yeast Beta-Glucan Market is clean-label yeast ingredient product development, with brands increasingly focusing on natural-origin, minimally processed, and transparent formulations. The shift toward simpler ingredient decks in food, skincare, and nutrition products continues to strengthen yeast beta-glucan adoption.

Supporting this innovation environment, Digital Agriculture at Cornell is being considered as a component of $30 million in settlement funding, which reflects wider investment in smarter and more sustainable ingredient ecosystems. This trend supports stronger product differentiation and premium positioning for yeast beta-glucan across multiple industries.

Advanced biotech fermentation capacity expansion

Another major trend is the expansion of advanced biotech fermentation capacity, which supports higher yield production, improved consistency, and scalable commercial availability of yeast beta-glucan. Fermentation-linked innovation is becoming central to long-term supply optimization and product customization.

A notable supportive development is Jamaica securing a US$50m Green Climate Fund boost for a major agriculture resilience project, reinforcing global momentum toward sustainable bio-based production systems. This trend is expected to further strengthen fermentation-driven innovation and capacity expansion opportunities in the yeast beta-glucan market.

Regional Analysis

Asia Pacific led with 42.3% share, reaching USD 158.5 Mn in the 2025 market.

In the Yeast Beta-Glucan Market, regional performance across North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America reflects varying levels of adoption shaped by end-use industry maturity and demand for functional ingredients.

Asia Pacific emerged as the dominating region, accounting for 42.3% of the global market and reaching a value of USD 158.5 Mn, supported by strong consumption across food, beverage, and nutraceutical applications. The region’s leadership position highlights its established manufacturing base, expanding health-conscious consumer population, and increasing use of yeast-derived functional ingredients in daily nutrition products.

North America and Europe continued to represent important regional markets, driven by stable demand from wellness-focused food and supplement categories, while Middle East & Africa and Latin America showed developing opportunities supported by gradual awareness and industrial adoption.

Although all major regions contribute to the overall market footprint, Asia Pacific remained the clear leader in both percentage share and market value, setting the benchmark for regional performance in 2025. Its 42.3% contribution and USD 158.5 Mn valuation firmly position it as the primary revenue-generating geography in the global Yeast Beta-Glucan Market.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of MEA

Key Players Analysis

In 2025, Cargill, Incorporated continued to hold a strong analyst-favored position in the global Yeast Beta-Glucan Market due to its broad expertise in food ingredients, nutrition systems, and scalable industrial processing capabilities. From an analyst’s perspective, Cargill’s strength lies in its ability to integrate yeast beta-glucan into functional food, beverage, and health-focused ingredient platforms where formulation reliability and global customer reach are critical. Its established relationships across multinational food and nutrition brands support deeper penetration of yeast-derived bioactive ingredients into mainstream wellness products.

In 2025, Lesaffre Human Care stands out from an analyst viewpoint for its specialized yeast heritage and deep scientific focus on human health applications. Its expertise in fermentation, probiotic yeast systems, and yeast fraction technologies provides a strong foundation for beta-glucan innovation in immune health and gut wellness categories. Analysts view the company’s focused human care positioning as a major advantage, particularly in supplement, preventive nutrition, and specialty health formulations where efficacy-backed yeast actives are highly valued.

In 2025, EMD Millipore maintained a distinctive strategic role in the global Yeast Beta-Glucan Market through its strong life science, laboratory, and pharmaceutical ingredient ecosystem. From an analyst perspective, the company’s value is centered on high-purity material standards, research-grade validation, and formulation compatibility for advanced health and biopharma applications. Its established credibility in scientific workflows supports greater adoption of yeast beta-glucan in precision nutraceutical, pharmaceutical, and research-led product development environments.

Top Key Players in the Market

• Cargill, Incorporated
• Lesaffre Human Care
• EMD Millipore
• Biorigin
• Kerry Group plc
• Lallemand, Inc.
• Specialty Biotech Co., Ltd.
• Van Wankum Ingredients
• Angel Yeast Co., Ltd.
• Leiber

Recent Developments

• In June 2025, Biorigin, which works in natural yeast-based ingredients for human food and animal nutrition, entered a major joint venture with Lesaffre after its 70% stake acquisition was completed. This development expanded its global yeast derivative capabilities, stronger R&D support, and wider customer solutions in natural savory and beta-glucan-related applications.
• In March 2024, EMD Millipore, which works in life science tools, lab materials, and bioprocess solutions, strengthened its Life Science platform through Merck’s acquisition of Mirus Bio in 2024. This development improved advanced biologics and research capabilities, supporting stronger high-purity yeast beta-glucan and related life science applications.

Report Scope